期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
徒手心肺复苏与Michigan Instruments,Inc.心肺复苏器在急诊科应用效果比较 被引量:1
1
作者 刘伯瑞 《中国医疗器械信息》 2023年第4期140-142,182,共4页
目的:分析比较在为急诊科患者实施心肺复苏治疗的过程中徒手心肺复苏与Michigan Instruments,Inc.心肺复苏器所获得的临床应用效果。方法:本次实验研究将2020年1月~2021年12月在本院急诊接受心肺复苏治疗的患者62例根据随机双盲法分为... 目的:分析比较在为急诊科患者实施心肺复苏治疗的过程中徒手心肺复苏与Michigan Instruments,Inc.心肺复苏器所获得的临床应用效果。方法:本次实验研究将2020年1月~2021年12月在本院急诊接受心肺复苏治疗的患者62例根据随机双盲法分为观察组(n=31)与对照组(n=31),其心肺复苏方式分别为Michigan Instruments,Inc.心肺复苏器与徒手心肺复苏。结果:观察组患者心肺复苏有效率、复苏后10min颈动脉血流平均速度、复苏时间、复苏后即刻乳酸值与血氧饱和度以及复苏后血气分析指标、并发症发生率均显著差别于对照组患者,P<0.05;心肺复苏后20min、30min两组患者颈动脉血流平均速度无显著差异,P>0.05。结论:对于急诊科需要接受心肺复苏治疗的患者来说Michigan Instruments,Inc.心肺复苏器的应用获得了较为显著的效果。 展开更多
关键词 徒手心肺复苏 michigan instruments Inc.心肺复苏器 急诊科
暂未订购
Michigan Instruments,Inc.心肺复苏器进行心肺复苏的效果及并发症研究
2
作者 史莹 《中国医疗器械信息》 2023年第22期86-88,共3页
目的:分析在实施心肺复苏的过程中Michigan Instruments,Inc.心肺复苏器的应用可以获得的效果及并发症发生情况。方法:本研究随机于医院接受心肺复苏的患者中选取56例开展实验研究,根据随机数字表法实现患者的分组,其中28例患者为实验组... 目的:分析在实施心肺复苏的过程中Michigan Instruments,Inc.心肺复苏器的应用可以获得的效果及并发症发生情况。方法:本研究随机于医院接受心肺复苏的患者中选取56例开展实验研究,根据随机数字表法实现患者的分组,其中28例患者为实验组,所采用的抢救方法为Michigan Instruments,Inc.心肺复苏器,另外28例患者为对比组,所采用的抢救方法为徒手人工心肺复苏。结果:实验组患者抢救效果相对较好,并发症发生率相对较低,收缩压与血氧饱和度、血氧分压、二氧化碳分压等指标更为理想,与对比组患者相比存在显著差异,P<0.05。结论:在实施心肺复苏的过程中想要获得更为理想的抢救效果对Michigan Instruments,Inc.心肺复苏器进行应用是非常重要的,在提高抢救效果的同时减少了并发症的出现,更好地改善了患者的相关临床指标。 展开更多
关键词 michigan instruments Inc.心肺复苏器 徒手人工心肺复苏 血氧分压
暂未订购
Validity and reliability of the Polish version of the Michigan Neuropathy Screening Instrument 被引量:4
3
作者 Edyta Sutkowska Dominik Marciniak +6 位作者 Magdalena Koszewicz Edyta Dziadkowiak Slawomir Budrewicz Karolina Biernat Natalia Kuciel Justyna Mazurek Katarzyna Hap 《World Journal of Diabetes》 SCIE 2023年第4期435-446,共12页
BACKGROUND Diabetic sensorimotor polyneuropathy is an important risk factor for foot ulceration and amputation.Thus,patients with diabetes should be screened for this disorder according to local guidelines.An obstacle... BACKGROUND Diabetic sensorimotor polyneuropathy is an important risk factor for foot ulceration and amputation.Thus,patients with diabetes should be screened for this disorder according to local guidelines.An obstacle to the diagnosis of this disease may be the lack of unified diagnostic criteria due to the lack of properly validated scales used for assessment.AIM To validate both sections(A and B)of the Michigan Neuropathy Screening Instrument(MNSI)in Polish(PL)patients with diabetes.METHODS A cross-sectional study using a test(A1,B1)and re-test(A2,B2)formula was performed in 80 patients with diabetes.The gold standard used for neuropathy detection was a nerve conduction study(NCS)which was performed in all participants.Reliability of the MNSI-PL was assessed using the Cronbach’s alpha,Kuder-Richardson formula 20(KR-20),split-half reliability,the Gottman split-half tests,and correlation between first and second half was accessed.Stability was assessed using an intraclass correlation coefficient(ICC).For external validation,we used simple linear correlation,binomial regression,and agreement between two different tools using a Bland-Altman plot analysis.RESULTS The scale was internally consistent(Cronbach’s alpha for the full scale:0.81 for A and 0.87 for B).MNSI-PL scores in test/retest showed high stability(ICC=0.73 for A and ICC=0.97 for B).The statistically important correlations between MNSI-PL and NCS were found for B1,B2,and A1(P<0.005).The cut-off points of≥3 for section A(sensitivity of 90%-100%;specificity of 33%-40%)and≥2 for section B(sensitivity of 81%-84%;specificity of 60%-70%)were obtained during neuropathy detection.CONCLUSION The MNSI-PL is a reliable and valid instrument in screening for diabetic neuropathy. 展开更多
关键词 michigan Neuropathy Screening Instrument Validity RELIABILITY Diabetic neuropathy Chronic complications
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部